Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice.
about
Treatment of recurrent depressionPsychostimulants for depressionIdentification and treatment of antidepressant tachyphylaxisThe neuronal transporter gene SLC6A15 confers risk to major depressionIn pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163).Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.The Impact of Residual Symptoms in Major DepressionPharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.Augmenting antidepressant medication treatment of depressed women with emotionally focused therapy for couples: a randomized pilot study.Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder.Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials.L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive Episode.Antidepressant-resistant depression and antidepressant-associated suicidal behaviour: the role of underlying bipolarity.Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.Combination pharmacotherapy in unipolar depression.Combining Stimulants and Monoamine Oxidase Inhibitors: A Reexamination of the Literature and a Report of a New Treatment Combination.The road to recovery from depression--don't drive today with yesterday's map.Combined treatments for major depression.The mental health clinic: a new modelCurrent trends in the assessment and somatic treatment of resistant/refractory major depression: an overview.Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies.The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder.Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model.Is lithium in a class of its own? A brief profile of its clinical use.Therapeutic armamentarium for treating depression.Quetiapine: novel uses in the treatment of depressive and anxiety disorders.Prodromal stage of major depression.Therapeutic options in treatment-resistant depression.Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression.How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.Augmentation and combination strategies to treat the residual symptoms of major depressive disorderDifferential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies.Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS' PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS.Melatonin synergizes with citalopram to induce antidepressant-like behavior and to promote hippocampal neurogenesis in adult mice.Evidence for two types of bipolar depression using a dimensional approach.
P2860
Q22305946-FD89820E-4861-4ECA-9C41-55F4E798BA79Q24243210-4B9945F9-F594-4F1F-B653-77FFF523094CQ24567527-C5901A68-F0C1-4954-9718-669A0101F373Q24617186-B98EE11B-2AC8-45BA-9C5F-BC5B8C0A2652Q30927398-7184ABE0-3973-4CBC-88F7-33BD43EDCEE3Q33587032-13AB27C9-ECB7-47E1-A9A8-0894BAEF5DE6Q33625345-B69CA8AF-64BC-4993-A7B4-AB012B5C2525Q33664080-D3B0273F-1589-4854-A776-9C618F2DF950Q33730306-70A45891-BDF0-4EDA-8005-47A4AC644664Q33918503-233A187E-B4C8-4AAE-8C99-BE631CDEDD17Q34027230-B4BBC87A-D619-4661-8C74-39D954AC4112Q34053662-941BA4B8-2995-4DD5-9978-E5D045EDB9B3Q34163886-00D7F890-5BC1-4159-9710-291D83D5A635Q34986537-2CC0EBAF-77A0-4AA3-BE73-8B8F1689FA9BQ35122330-F3F4ACBD-81BA-4394-9905-85D24523239BQ36100305-5F3B15E5-4ACD-424C-A90B-87BE99DEACE9Q36532163-AC6953DD-36B4-4E0B-BCDF-24088917ED66Q36722925-CD84D37A-4F11-497C-9FC8-F493FF60315FQ36910850-B749CACB-F84A-4FDD-921E-659219F91FC9Q36916862-890D2796-0649-4606-AB96-D4445E108CA0Q36919963-F0AE3015-4869-4413-AACF-66CA95B2837FQ37091883-D4A61287-F8F8-421A-9D55-C4191B56B15BQ37101731-E2A6E7CA-E23C-49C4-A0C4-1D5A2F9DBAE1Q37141494-21566C88-BB2D-4FF0-84DE-BDE878DBEE3CQ37289129-08E3F5FB-BFF8-433A-815C-98A3517ED8E7Q37334485-70AE63BC-4FF0-4C1F-8619-4984BD044C0CQ37650273-76078E73-9D0F-4805-BF61-2B7A64CE19BAQ37777008-52ED9C99-0D93-422D-B05D-3596CAE39781Q37783300-79F6DFE4-63D8-4A8F-A5F8-21AE18EDC5C6Q37847192-A7372F9B-FEA1-42B7-996D-124C6ACB8B83Q37881968-43E1AC31-9481-4881-A883-1A110D39334EQ38109864-3D382091-243F-40C9-9674-199E8DC9C34EQ41595348-5EC124CE-48EA-4CA1-9215-076BA84B463FQ42110803-65492676-A17F-45A7-A565-1A802C088806Q46882607-54C6A6F9-909C-4A1B-BF07-D88FAC200F61Q47557944-271D6F0E-EFF6-4331-8E61-460304DBF420Q47740187-7355E298-8D71-4FB0-89E5-03A4CAAC0144Q48079070-929CF83D-F81A-426A-BBA8-4616A968DB69Q48330847-B4C97A21-3DD1-4E69-BBAB-B59A6B592847Q48381031-50D9DC02-E930-49CA-9018-FCCB70671756
P2860
Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Current status of augmentation ...... approach to improve practice.
@ast
Current status of augmentation ...... approach to improve practice.
@en
type
label
Current status of augmentation ...... approach to improve practice.
@ast
Current status of augmentation ...... approach to improve practice.
@en
prefLabel
Current status of augmentation ...... approach to improve practice.
@ast
Current status of augmentation ...... approach to improve practice.
@en
P2860
P356
P1476
Current status of augmentation ...... l approach to improve practice
@en
P2093
Maurizio Fava
P2860
P304
P356
10.1159/000091771
P577
2006-01-01T00:00:00Z